Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US

Tuesday, March 10, 2026

9:36 AM - 10:00 AM EST

Location: International Ballroom West

Moderator(s)

Kendra J. Grubb, MD

VP/CMO Structural Heart
Medtronic
Atlanta, Georgia, United States

Disclosure(s): Medtronic, Inc.: Employee (Ongoing)
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.

Panel Discussant(s)

Keith B. Allen, MD

Director of Surgical Research and Surgical Director of Structural Heart, St. Luke’s Hospital, Kansas City, MO
St. Luke's Mid America Heart Institute
Shawnee, Kansas, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Danny Chu, MD

Professor of Cardiothoracic Surgery
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States

Disclosure(s): Sanamedi, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing)
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

Disclosure(s): No financial relationships to disclose
Scott Lim, MD

Professor of Medicine
University of British Columbia
Vancouver, British Columbia, Canada

Disclosure information not submitted.
Ignacio Lugones, MD PhD

Head of Cardiac Surgery Unit
Children's Hospital of Buenos Aires "Dr. Pedro de Elizalde", Argentina

Disclosure(s): AVaTAR MedTech: Owner/Co-Owner Founder/Co-Founder (Ongoing)
Duane Pinto, MD, MPH, FSCAI

Chief Medical Officer
JenaValve
Boston, Massachusetts, United States

Disclosure(s): AriaCV: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Employee (Ongoing); NupulseCV: BOD (Ongoing)
Patrick W. Serruys, MD, PhD

Professor of Medical Intervention & Innovation
University of Galway, Ireland

Disclosure information not submitted.

Disclosure(s):

Kendra J. Grubb, MD: Medtronic, Inc.: Employee (Ongoing)

Keith B. Allen, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Danny Chu, MD: Sanamedi, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing)

Yair Feld, MD, PhD: No financial relationships to disclose

Isaac George, MD: Atricure: Consulting Fees (e.g., advisory boards) (Ongoing); BCI: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); CardioMech: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); DurVena Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing); ZimmerBioMet: Consulting Fees (e.g., advisory boards) (Ongoing)

Ignacio Lugones, MD PhD: AVaTAR MedTech: Owner/Co-Owner Founder/Co-Founder (Ongoing)

Duane Pinto, MD, MPH, FSCAI: AriaCV: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Employee (Ongoing); NupulseCV: BOD (Ongoing)